Loading…
Loading…
CHMMF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CHMMF and 80,000+ other tickers.
See exactly how CHMMF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CHMMF and 80,000+ other tickers.
Chimeric Therapeutics Limited is an Australian biotechnology firm operating at the clinical stage, dedicated to advancing and commercializing a diverse portfolio of cell-based treatments specifically for cancer. Its pipeline features several promising candidates. CHM 0201, utilizing a core natural killer (NK) cell platform, is currently undergoing Phase I clinical trials for the treatment of both solid tumors and hematological malignancies. Another key program, CHM 1101 (a CLTX CAR T-cell therapy), is also in Phase I development, specifically targeting patients with recurrent or progressive…
Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for its CHM CDH17 cell...
Imugene Ltd (ASX:IMU, OTC:IUGNF) has won crucial backing from the US Food and Drug Administration (FDA), with written minutes from a recent Type C meeting...
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has signed a Mining Agreement with Nyamal Aboriginal Corporation (NAC) covering the Mt York Gold Project in the...
Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received a research and development (R&D) tax incentive refund of $4,497,886 under the Australian...
Altech Batteries Ltd (ASX:ATC, OTC:ALTHF) has attracted fresh industry attention after one of the world’s largest electric vehicle battery manufacturers...